Related Experiment Video
Updated: Jul 4, 2025

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.4K
Loss of Myo19 increases metastasis by enhancing microenvironmental ROS gradient and chemotaxis
Xiaoyu Ren1, Peng Shi2,3, Jing Su4
1Institute of Systems Biomedicine, Peking University Health Science Center, Key Laboratory of Tumor Systems Biology, Beijing, 100191, China.
EMBO Reports
|January 26, 2024
Summary
Hydrogen peroxide (H2O2) acts as a chemoattractant, guiding tumor cells during metastasis. Loss of Myosin 19 (Myo19) protein disrupts mitochondria, enhancing this effect and promoting cancer spread.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Tumor metastasis involves directed cell migration influenced by chemical signals.
- Hydrogen peroxide (H2O2) is a known neutrophil chemoattractant, but its role in tumor cell dissemination is unclear.
- The spatial distribution of reactive oxygen species (ROS) in the tumor microenvironment is not well understood.
Purpose of the Study:
- To investigate the spatial distribution of ROS in 3D tumor spheroids.
- To determine the role of H2O2 gradients in tumor cell chemotaxis and metastasis.
- To explore the function of mitochondria and Myosin 19 (Myo19) in regulating ROS gradients and tumor dissemination.
Main Methods:
- 3D tumor spheroid models were used to analyze ROS distribution.
- Chemotaxis assays were performed to assess tumor cell migration in response to H2O2 gradients.
- Molecular pathways involving Src and RhoA were investigated.
- The role of mitochondria and Myo19 in ROS production and tumor cell dissemination was examined.
Main Results:
- A ROS concentration gradient, specifically H2O2, was identified in the periphery of 3D tumor spheroids and the tumor microenvironment.
- The H2O2 gradient induces tumor cell chemotaxis by activating Src and inhibiting RhoA.
- Absence of mitochondria cristae remodeling proteins, like Myo19, enhances the ROS gradient and promotes tumor dissemination.
- Myo19 downregulation correlates with increased tumor metastasis in vivo.
Conclusions:
- Tumor microenvironmental ROS, particularly H2O2, function as chemoattractants for tumor cells.
- Mitochondrial dysfunction, specifically impaired cristae remodeling due to proteins like Myo19, can enhance ROS gradients and promote tumor invasion and metastasis.
- Myo19 downregulation is observed in various tumors and is negatively associated with metastasis, suggesting its potential as a therapeutic target.
Related Concept Videos
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Chemotaxis and Direction of Cell Migration
3.4K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.4K

